Sep 15, 2016

Verily, Alphabet and Google Look to Cure Diabetes – With Nanobots?

Posted by in categories: biotech/medical, nanotechnology

Another example where big tech and biology are blurring the lines.

Sanofil is a target of Verily, an Alphabet Division (Google 2.0) – and they may have a nifty nanobot cure for diabetes.

Read more

Comments are closed.